Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Poly(A) binding protein cytoplasmic 1 pseudogene 12 (PABPC1P12)** is a human gene classified as a pseudogene. It is related by sequence to the poly(A) binding protein cytoplasmic 1 (PABPC1), which has established functions in mRNA stability, translation, and export. However, PABPC1P12 is annotated as a pseudogene, meaning it does not encode a functional protein and lacks known molecular or biological activity. There is currently no evidence supporting a role for PABPC1P12 in disease, drug action, or as a biomarker[1][2][3][6][7][8]. **Key assessment:** PABPC1P12 is not a conventional drug target (i.e., not a receptor, enzyme, transporter, or transcription factor) but rather a non-coding pseudogene, so it should not be considered a therapeutic or drug development target[3][5][7][8]. If you require data for the functional protein, refer to **PABPC1** (poly(A) binding protein cytoplasmic 1)[11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A) binding protein cytoplasmic 1 pseudogene 12 (PABPC1P12).